Potential predictive markers of chemotherapy for advanced gastric cancer: Biomarker study in GC0301/TOP-002, randomized phase III study of irinotecan plus S-1 versus S-1.
Naotoshi Sugimoto
No relevant relationships to disclose
Akira Tsuburaya
No relevant relationships to disclose
Ryohei Kawabata
No relevant relationships to disclose
Kazuhiro Nishikawa
No relevant relationships to disclose
Haruhiko Imamoto
No relevant relationships to disclose
Toshimasa Tsujinaka
No relevant relationships to disclose
Taito Esaki
No relevant relationships to disclose
Yosuke Horita
No relevant relationships to disclose
Yutaka Kimura
No relevant relationships to disclose
Tsuneaki Fujiya
No relevant relationships to disclose
Osamu Takayama
No relevant relationships to disclose
Ryo Oono
No relevant relationships to disclose
Hiroshi Yabusaki
No relevant relationships to disclose
Masataka Taguri
No relevant relationships to disclose
Satoshi Morita
No relevant relationships to disclose
Wasaburo Koizumi
No relevant relationships to disclose
Patrick Tan
No relevant relationships to disclose
Motoki Ninomiya
No relevant relationships to disclose
Hiroshi Furukawa
No relevant relationships to disclose
Mitsuru Sasako
No relevant relationships to disclose